Sodium phosphate enemas do not worsen renal function among hospitalized patients with mild to moderate renal failure: a matched, case-control study.

A Dagan¹, G Y Stein^2,3, S Winter³, C Avaky¹, L Hofstetter¹, I Gringauz¹, A Biber¹, G Segal¹

¹From the Department of Internal Medicine T (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Chaim Sheba Medical Center, Ramat Gan.

²Department of Internal Medicine B (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Rabin Medical Center, Beilinson Hospital, Petach Tikva.

³MedAware Ltd., Raanana, Israel.

PubMed DOI

Abstract

BACKGROUND: Sodium phosphate enemas (SPEs) are widely used among hospitalized patients despite their potential to worsen renal failure. AIM: We decided to assess the extent to which this side effect is clinically relevant. DESIGN: We conducted a matched case-control, retrospective study in a cohort of hospitalized patients. METHODS: Patients treated and untreated with SPEs were matched for age,…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.